000 02276cam  2200433zi 4500
0019.932085
003CaOODSP
00520240221071920
006m     o  d f      
007cr mn|||||||||
008240104s2023    onc     obs  f000 0 eng d
020 |a9780660694825
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay2y2
0861 |aPS82-4/23-31E-PDF
1001 |aFiloso, Daniella, |eauthor.
24510|aPrevalence of SARS-CoV-2 antibodies among federally incarcerated men / |cprepared by Daniella Filoso & Kayla Wanamaker.
264 1|a[Ottawa] : |bCorrectional Service Canada = Service correctionnel Canada, |c2023
300 |a1 online resource (1 page).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aResearch in brief ; |vRIB-23-31
500 |aIssued also in French under title: Prévalence d'anticorps contre le SRAS-CoV-2 chez les détenus de sexe masculin sous responsabilité fédérale.
504 |aIncludes bibliographical references.
520 |a"In collaboration with Public Health Agency of Canada (PHAC) and the University of Ottawa, Correctional Service Canada (CSC) conducted the 2022 National Health Survey. One of the study objectives was to determine the prevalence of SARS-CoV-2 antibodies and whether they are derived from immunization or infection among federally incarcerated men."
650 0|aMale prisoners|xDiseases|zCanada|vStatistics.
650 0|aCOVID-19 (Disease)|zCanada|vStatistics.
650 0|aCOVID-19 (Disease)|xVaccination|zCanada|vStatistics.
650 0|aViral antibodies.
655 7|aStatistics|2lcgft
7102 |aCorrectional Service Canada, |eissuing body.
77508|tPrévalence d'anticorps contre le SRAS-COV-2 chez les détenus de sexe masculin sous responsabilité fédérale / |w(CaOODSP)9.932086
830#0|aResearch in brief (Correctional Service Canada)|vRIB-23-31.|w(CaOODSP)9.805030
85640|qPDF|s218 KB|uhttps://publications.gc.ca/collections/collection_2024/scc-csc/PS82-4-23-31-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/correctional-service/corporate/library/research/research-brief/23-31.html